The landscape of oncology is currently undergoing a paradigm shift, driven by rapid advancements in molecular diagnostics,...
For many patients, the end of active breast cancer treatment—the final chemotherapy infusion or the closing of...
On July 23, 2026, the United States Department of Health and Human Services (HHS) finalized a sweeping...
Written by Douglas Feil, NBCF Chief Program Officer Medical Disclaimer: The information provided in this article is...
For decades, the standard path for breast reconstruction following a mastectomy has been binary: either the insertion...
The biotechnology sector continues to navigate a complex landscape of clinical setbacks, regulatory breakthroughs, and tactical financial...
In the landscape of modern drug discovery, a profound paradigm shift is underway. For decades, the pathology...
NEW YORK, NY — October 8, 2026 — As Breast Cancer Awareness Month unfolds across the globe,...
AMMAN — The Hashemite Kingdom of Jordan has once again cemented its status as a vital anchor...
For many patients, the end of active breast cancer treatment—chemotherapy, radiation, or surgery—is not the finish line,...
